Work

Humanized chimeric antigen receptor (CAR)-modified T cells targeting CD19 induce remissions in children and young adults with relapsed/refractory lymphoblastic leukemia/lymphoma

Year: 2017

Type: article

Study design: Clinical Trial

Source: Cytotherapy

DOI: 10.1016/j.jcyt.2017.02.011

Institutions: Children's Hospital of Philadelphia, University of Pennsylvania

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2610338981

FWCI: 0.433

Cites:

Cited by: 7

Related to: 10